How does Duloxetine (Cymbalta) affect sleep?

From the FDA Drug Label

Duloxetine delayed-release capsules can cause sleepiness or may affect your ability to make decisions, think clearly, or react quickly. Common possible side effects in people who take duloxetine delayed-release capsules include: ... sleepiness Discontinuation symptoms: ... problems sleeping Manic episodes: ... severe trouble sleeping The most commonly observed adverse reactions in duloxetine delayed-release capsules-treated patients (as defined above) were: ... somnolence, insomnia

Duloxetine can affect sleep in several ways, including causing:

• Sleepiness (somnolence) as a common side effect
• Insomnia as a common side effect
• Severe trouble sleeping as a symptom of manic episodes
• Problems sleeping as a discontinuation symptom when stopping the medication too quickly

1, 1, 1

From the Research

Duloxetine can have both positive and negative effects on sleep, and its impact depends on individual response and timing of administration, with the most recent evidence suggesting that it may increase stage 3 sleep and suppress rapid eye movement (REM) sleep in patients with major depression 2.

Effects of Duloxetine on Sleep

The medication can cause insomnia in some patients, while improving sleep quality in others, particularly those whose sleep is disrupted by pain or depression.

• Duloxetine's dual action on serotonin and norepinephrine explains its varied effects on sleep, with increased norepinephrine potentially promoting wakefulness and alertness, and serotonin modulation improving sleep architecture in some individuals.
• The standard dosing ranges from 30-60mg daily, though some patients require up to 120mg daily for therapeutic effect.
• For best results with sleep, duloxetine should typically be taken in the morning rather than evening, as its activating effects can interfere with falling asleep when taken later in the day.

Clinical Impact of Duloxetine on Sleep

Studies have shown that duloxetine can improve sleep in patients with major depressive disorder, with significant improvements in core emotional symptoms and painful physical symptoms associated with depression 3, 4.

• However, sleep-related treatment-emergent adverse events, such as insomnia and hypersomnia, can occur in some patients.
• Patients experiencing persistent sleep problems should consult their healthcare provider, as timing adjustments, dose modifications, or additional sleep interventions may be necessary.

Comparison with Other Treatments

Duloxetine has been compared to other treatments for major depressive disorder, including paroxetine and escitalopram, and has been shown to have a similar global benefit-risk profile 4.

• Melatonin, an endogenous hormone produced by the pineal gland, has also been shown to be effective in improving sleep quality and has been proposed as an alternative treatment to currently available pharmaceutical therapies for sleep disorders 5.